Nabilone for chronic pain management: a review of clinical effectiveness, safety, and guidelines
CADTH
Record ID 32012000035
English
Authors' recommendations:
Limited evidence suggests that nabilone may be better than placebo in relieving chronic pain but its relative benefits compared to other analgesics have not been proven. Current guidelines recommend the dosage of nabilone for treating neuropathic pain be titrated gradually until target relief is obtained.
Details
Project Status:
Completed
Year Published:
2011
URL for published report:
http://www.cadth.ca/media/pdf/htis/oct-2011/RC0306-000%20Nabilone%20for%20chronic%20pain.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Chronic Disease
- Pain
- Anti-Anxiety Agents
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.